Remedor Biomed News
1 article
growth-positive
Patents Assigned to Remedor Biomed Ltd. - Justia Patents Search
The article discusses patents assigned to Remedor Biomed Ltd. for topical erythropoietin formulations and methods for improving wound healing and cosmetic use. The patents describe the use of erythropoietin and fibronectin in topical formulations to accelerate wound healing and promote connective tissue reconstruction. The formulations are applied topically and have shown to improve wound healing compared to the healing process without the formulation. The patents also disclose unit dosage forms, pharmaceutical compositions, cosmetic compositions, and formulations containing erythropoietin and/or fibronectin. The article does not mention any specific customers, partners, investment, acquisition, public trading, management changes, layoffs, or plans for expansion. The event described in the article is the granting of patents to Remedor Biomed Ltd. The confidence in the answer is 8.
Customers